Advanced search×


Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Proquest, Rcgp, CSA, Ingenta, Wiley from 1948, Gale, and Ovid from 2005

  1. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prost...

    Cancer 120(8):1263 (2014) PMID 24510400

    The authors investigated the prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction in a contemporary, population-based prostate cancer cohort. They also explored the associations between baseline function and age, comorbidity, and timing of baseline survey completion with respe...
  2. Comparison of secondary and primary thyroid cancer in adolescents and young adults.

    Cancer 120(8):1155 (2014) PMID 24615715

    Thyroid cancer is one of the 5 most common malignancies in adolescent and young adult (AYA) patients (ages 15-39 years) and may develop de novo or in patients previously treated for cancer. This study compared the tumor characteristics, treatment, and overall survival (OS) of secondary malignant neo...
  3. Biological factor may be linked to prostate cancer racial disparities.

    Cancer 120(8):1132 (2014) PMID 24715301

  4. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.

    Cancer 120(7):963 (2014) PMID 24415441

    We identified 12 disease-associated PALB2 mutations among the 1479 patients (0.8%). The PALB2 mutations included 8 nonsense, 3 frameshift mutations and a splice-site mutation. The mutation prevalence for the high-risk population was 1.05% (95% CI = 0.5-1.92), whereas that for the lower-risk populati...
  5. Consensus statement released for treating melanoma patients with immunotherapy.

    Cancer 120(1):3 (2014) PMID 24347380

  6. Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis.

    Cancer 119(5):1004 (2013) PMID 23132729

    The promoter of Id4 was methylated in 23 of 62 (37%) GBMs. In methylated GBMs, Id4 mRNA was significantly reduced, compared with unmethylated GBMs (P = .0002). A significant reduction of protein expression was detected in all hypermethylated cases. GBMs with methylated Id4 showed a significant reduc...
  7. Dramatic rise in skin cancer seen in young adults.

    Cancer 118(16):3881 (2012) PMID 22864931

  8. Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Canc...

    Cancer 118(5):1422 (2012) PMID 21823111

    For patients with lung, pancreatic, and head and neck tumors who were treated on phase 1 trials, survival was predicted accurately by the RMH prognostic score. Cancer 2011;. © 2011 American Cancer Society. Copyright © 2011 American Cancer Society....
  9. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patient...

    Cancer 118(5):1457 (2012) PMID 21837676

    The final QLQ-BM22 module contains 22 items and 4 scales assessing Painful Sites, Painful Characteristics, Functional Interference, and Psychosocial Aspects. Results confirmed the validity, reliability, cross-cultural applicability, and sensitivity of the 22-item EORTC QLQ-BM22. It is therefore reco...
  10. Clinical outcomes of oncologic gastrointestinal resections in patients with cirrhosis.

    Cancer 118(14):3494 (2012) PMID 22170573

    Resection of GI malignancy in cirrhotics is associated with poor early postoperative and transitional outcomes, with severity of liver disease being the primary determinant of postoperative mortality. These data suggest that GI cancer operations can be performed safely in well-selected cirrhotic pat...